Natus Medical Stock Company Profile

Description

Natus Medical Incorporated designs, manufactures, and markets newborn care and neurology healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. It offers neurology products, such as diagnostic electroencephalography and long-term monitoring products, electrodiagnostic monitoring products, diagnostic polysomnography monitoring products, diagnostic intraoperative monitoring products, and transcranial Doppler products. The company also provides newborn care products, including hearing screening products to screen the hearing; brain injury products to diagnose the severity of brain injury, monitor the effectiveness of drug therapies, detect seizure activity, and monitor general neurological status; and thermoregulation products to control the newborn environment, including incubators and warmers. Its newborn care also comprise jaundice management products to measure bilirubin levels and treat jaundice; diagnostic hearing assessment products to screen for or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems in patients of all ages; balance and mobility systems to diagnose and assist in treating balance disorders; and NicView video for families with babies in the neonatal intensive care unit. The company serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in Pleasanton, California.